| Mitoxantrone and the new drug approval process |
| MD Abeloff |
|
JCO May 1 1989: 551–553.
[PDF]
|
 |
| Doxorubicin as adjuvant therapy for breast cancer: answers or more questions? |
| PP Carbone |
|
JCO May 1 1989: 554–556.
[PDF]
|
|
| Now we tell--but how well? |
| JC Holland |
|
JCO May 1 1989: 557–559.
[PDF]
|
|
|
Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer |
| |
IC Henderson, JC Allegra, T Woodcock, S Wolff, S Bryan, K Cartwright, G Dukart, and D Henry |
| |
JCO May 1 1989: 560–571.
[Abstract]
[PDF]
|
|
|
Doxorubicin-containing regimens for the treatment of stage II breast cancer: The National Surgical Adjuvant Breast and Bowel Project experience |
| |
B Fisher, C Redmond, DL Wickerham, D Bowman, H Schipper, N Wolmark, R Sass, ER Fisher, P Jochimsen, and S Legault-Poisson |
| |
JCO May 1 1989: 572–582.
[Abstract]
[PDF]
|
|
|
Telling the diagnosis of cancer |
| |
SE Lind, MJ DelVecchio Good, S Seidel, T Csordas, and BJ Good |
| |
JCO May 1 1989: 583–589.
[Abstract]
[PDF]
|
|
|
Treatment of metastatic prostatic cancer with low-dose prednisone: evaluation of pain and quality of life as pragmatic indices of response |
| |
I Tannock, M Gospodarowicz, W Meakin, T Panzarella, L Stewart, and W Rider |
| |
JCO May 1 1989: 590–597.
[Abstract]
[PDF]
|
|
|
Small lymphocytic lymphoma |
| |
WH Morrison, RT Hoppe, LM Weiss, VJ Picozzi, Jr, and SJ Horning |
| |
JCO May 1 1989: 598–606.
[Abstract]
[PDF]
|
|
|
Combined small-cell and non-small-cell lung cancer |
| |
MD Mangum, FA Greco, JD Hainsworth, KR Hande, and DH Johnson |
| |
JCO May 1 1989: 607–612.
[Abstract]
[PDF]
|
|
|
Patterns of relapse in large-cell lymphoma patients with bulk disease: implications for the use of adjuvant radiation therapy |
| |
MA Shipp, MM Klatt, B Yeap, MS Jochelson, PM Mauch, DS Rosenthal, AT Skarin, and GP Canellos |
| |
JCO May 1 1989: 613–618.
[Abstract]
[PDF]
|
|
|
The prognostic significance of residual pigmentation following radiotherapy of epidemic Kaposi's sarcoma |
| |
JS Cooper, AD Steinfeld, and IA Lerch |
| |
JCO May 1 1989: 619–621.
[Abstract]
[PDF]
|
|
|
Patient-specific dose rate for continuous infusion high-dose cytarabine in relapsed acute myelogenous leukemia |
| |
V Heinemann, E Estey, MJ Keating, and W Plunkett |
| |
JCO May 1 1989: 622–628.
[Abstract]
[PDF]
|
|
|
Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects |
| |
JA Thompson, DJ Lee, P Kidd, E Rubin, J Kaufmann, EM Bonnem, and A Fefer |
| |
JCO May 1 1989: 629–637.
[Abstract]
[PDF]
|
|
|
Prognostic factors for children with recurrent Wilms' tumor: results from the Second and Third National Wilms' Tumor Study |
| |
P Grundy, N Breslow, DM Green, K Sharples, A Evans, and GJ D'Angio |
| |
JCO May 1 1989: 638–647.
[Abstract]
[PDF]
|
|
|
An evaluation of outpatient bone marrow harvesting |
| |
JM Brandwein, J Callum, M Rubinger, JG Scott, and A Keating |
| |
JCO May 1 1989: 648–650.
[Abstract]
[PDF]
|
|
|
A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support [published erratum appears in J Clin Oncol 1989 Aug;7(8):1177] |
| |
TC Shea, M Flaherty, A Elias, JP Eder, K Antman, C Begg, L Schnipper, E Frei, 3d, and WD Henner |
| |
JCO May 1 1989: 651–661.
[Abstract]
[PDF]
|
|
|
A phase I study of intraarterial iododeoxyuridine in patients with colorectal liver metastases |
| |
AE Chang, JM Collins, PA Speth, R Smith, JB Rowland, L Walton, MG Begley, E Glatstein, and TJ Kinsella |
| |
JCO May 1 1989: 662–668.
[Abstract]
[PDF]
|
|
|
Tripe palms and malignancy |
| |
PR Cohen, ME Grossman, L Almeida, and R Kurzrock |
| |
JCO May 1 1989: 669–678.
[Abstract]
[PDF]
|
|
| Castration induced by cytotoxic chemotherapy |
| H Brincker, HT Mouridsen, KW Andersen, C Rose, and P Dombernowsky |
|
JCO May 1 1989: 679–680.
[PDF]
|
|
| Leucovorin calcium enhancement of mucositis after continuous infusion fluorouracil and short infusion cisplatin |
| F Figoli, V Chiarion Sileni, M Gulisano, P Maggian, and V Fosser |
|
JCO May 1 1989: 680–681.
[PDF]
|
|
| Dose intensity: a critique of a critical review |
| WM Hryniuk |
|
JCO May 1 1989: 681–684.
[PDF]
|
|
| Transplantation versus chemotherapy in acute leukemia |
| EA Copelan |
|
JCO May 1 1989: 684–685.
[PDF]
|
|
| Intraperitoneal chemotherapy for ovarian carcinoma |
| RC Shepard |
|
JCO May 1 1989: 685.
[PDF]
|
|
| Hypothyroidism after interleukin-2 therapy |
| LC Hartmann, WJ Urba, RG Steis, JW Smith, 2d, L VanderMolen, SP Creekmore, and DL Longo |
|
JCO May 1 1989: 686–687.
[PDF]
|
|
| Cancer chemotherapy: ethical dilemmas |
| MB Van Scoy-Mosher |
|
JCO May 1 1989: 687.
[PDF]
|
|
